EP2861599
REVERSIBLE COVALENT PYRROLO- OR PYRAZOLOPYRIMIDINES USEFUL FOR THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.6.2013EP published:
18.12.2019EP application number:
13731218.7
EPO information:
European Patent Register
Max expiry date:
10.6.2033
Title:
REVERSIBLE COVALENT PYRROLO- OR PYRAZOLOPYRIMIDINES USEFUL FOR THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES
Timeline
Today
11.6.2013EP application
18.12.2019EP Publication
Owner
Name:
Principia Biopharma Inc.Address:
220 E. Grand Ave., S. San Francisco, CA 94080, US
Inventor
Name:
GOLDSTEIN, David MichaelAddress:
Redwood City, California 94061, US
Name:
BERNER, BretAddress:
Seattle WA 98116, US
Priority
Number:
201261661203 PDate:
18.6.2012Country:
US
Classification
Categories:
C07D 487/04, A61K 31/519, A61P 35/00, A61P 37/06